Urea Cycle Disorder Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 25
SKU : PH3491
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
Which region holds the largest market share of global urea cycle disorders treatment market ?
North America region holds the largest market share of global urea cycle disorders treatment market
Who are the key players in Urea Cycle Disorder Treatment Market ?
Major players are Horizon Pharma plc. Lucane Pharma, Recordati Rare Diseases Inc., Synlogic, Acer Therapeutics, Ultragenyx Pharmaceutical Inc., Aeglea BioTherapeutics, Arcturus Therapeutics Holdings, Orpharma Pty Ltd and Bausch Health Companies, Inc.
Related Reports
pharmaceuticalsBreathing Disorder Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 December 29
Starting from
$4350
pharmaceuticalsPigmentation Disorder Treatment Market Size, Share, Forecast and outlook (2024-2031)
Published: 2024 January 10
Starting from
$4350
pharmaceuticalsBleeding Disorders Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 March 04
Starting from
$4350